Can We Identify Risk for Drug Toxicity?
Drawing on recent developments, Dr. David Kerr suggests that DNA technology could identify markers that correlate with the risk of developing serious cancer drug side effects. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - August 26, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
'Would You Sell Your Soul for $10?'
Dr. Bruce Cheson forecasts that the Sunshine Act, requiring physicians to disclose most payment and gifts from industry over $10, will bring showers of misinterpretation and could hinder research. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - August 26, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
TWiV 247: Today's weather in virology
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler
Special guest: Ian Lipkin
Ian joins Vincent, Alan, Rich, and Kathy to describe how his laboratory is searching for the origin of MERS-coronavirus.
Links for this episode:
MERS-CoV in bats (EID)
Mystery virus (NY Times)
Part of MERS-CoV found in bat (virology blog()
T. perforatus
Frag virus (Virol J)
Even Nature got it wrong! (Nature)
Bats: Important reservoirs of emerging viruses (Clin Micro Rev)
Letters read on TWiV 247
Weekly Science Picks
Kathy - Rainbows explained (Frazz)Ala...
Source: This Week in Virology - MP3 Edition - August 26, 2013 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
New Tool Cracks the 'Old Chestnut' of Tumor Response
Dr. David Kerr discusses time to tumor growth, a metric that outscored all other means of characterizing tumor response rate and correlated with overall survival in patients with colorectal cancer. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - August 19, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Laboratory-Developed Tests: Will Regulation Help or Hinder?
How do we balance the need for certain lab tests with the overriding requirement to protect the public? Paul Auwaerter, MD, offers his opinion on this complex topic. (Source: Medscape HIV AIDS Podcast)
Source: Medscape HIV AIDS Podcast - July 24, 2013 Category: HIV AIDS Authors: Medscape Source Type: podcasts
Laboratory-Developed Tests: Will Regulation Help or Hinder?
How do we balance the need for certain lab tests with the overriding requirement to protect the public? Paul Auwaerter, MD, offers his opinion on this complex topic. (Source: Medscape Infectious Disease Podcast)
Source: Medscape Infectious Disease Podcast - July 24, 2013 Category: Infectious Diseases Authors: Medscape Source Type: podcasts
Laboratory-Developed Tests: Will Regulation Help or Hinder?
How do we balance the need for certain lab tests with the overriding requirement to protect the public? Paul Auwaerter, MD, offers his opinion on this complex topic. (Source: Medscape HIV AIDS Podcast)
Source: Medscape HIV AIDS Podcast - July 24, 2013 Category: Infectious Diseases Authors: Medscape Source Type: podcasts
Mok and Scagliotti: What You Need to Know About Afatinib
A Skype conversation between Drs. Tony Mok and Giorgio Scagliotti details the efficacy and potential toxicities of afatinib, which is newly approved by the FDA for EGFR-positive lung cancer patients. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - July 12, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Most Genetic Diabetes Misdiagnosed
The vast majority of monogenic diabetes is misdiagnosed as either type 1 or type 2 diabetes, leading to poor disease management. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - July 11, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
CD19-Targeted T Cells Rapidly Induce Remissions in Acute Lymphoblastic Leukemia -- Sloan-KEttering
Medical oncologist Renier Brentjens describes an innovative therapy developed at Memorial Sloan-Kettering in which a patient's own T cells are modified in the laboratory with an artificial receptor (c...
Author: mskcc
Added: 06/18/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 18, 2013 Category: Cancer & Oncology Source Type: podcasts
The ACOG Cervical Screening Guidelines: Key Changes
Sandra Fryhofer reviews the new cervical screening guidelines from the American College of Obstetrics and Gynecology and why they matter. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - May 24, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
Can BRCA Expression Predict Response to Chemotherapy?
Dr. Maurie Markman reviews a recent paper looking at whether differences in BRCA expression might predict response to IP vs IV chemotherapy in patients with ovarian cancer. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - April 22, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
